Applying PGx-guided drug therapy in decision making for diabetes and elderly patients
The use of clopidogrel and PPIs either alone or in combination is [...]
Personalized Medicine for patients with depression and/or anxiety
The literature on pharmacogenomics as a tool to support antidepressant precision is [...]
A large fraction of elderly Danes are exposed to drugs with “actionable guidelines”
A Danish register study shows that 49 drugs have "actionable guidelines" related [...]
FDA: pharmacogenomics can play an important role in identifying responders to medication
Pharmacogenomics can play an important role in identifying responders and non-responders [...]
Approx. half the population over 65 years in Germany can have an elevated risk
Around 9 million of the 17 million individuals aged ≥65 years [...]
Plavix manufacturers to pay $834 million in penalty
Bristol-Myers Squibb Co and Sanofi, the manufacturers of Plavix (clopidogrel) have been [...]
Adverse drug reactions are a major health concern worldwide
There are multiple causes of adverse drug reactions, some of which are [...]
Nearly 30% of children could benefit from study finds
Improving drug safety with genomics Manzi teamed up with Dianbo Liu, PhD, [...]
Mental health disorders account for 6.2% of healthcare spendings in the USA
Pharmacogenetic-guided psychiatric intervention associated with increased adherence to treatment and cost savings. [...]